Curative Biotechnology Inc
CUBT
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.55M
Close$
$-0.00
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.55 Million |
|---|---|
| Enterprise Value | $10.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.39 |
| Outstanding Shares | 7,369,867 |
Return
| Return on Equity | 41.84% |
|---|---|
| Return on Assets | -127.43% |
| Return on Invested Capital | 27.12% |
Valuation & Multiples
| P/E Ratio | -12.11 |
|---|---|
| PEG | 52.23 |
| Price to Sales | - |
| Price to Book Ratio | -1.4 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -6.38 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | -0.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data